06:11 EDT Ocular Therapeutix (OCUL) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- Ocular Therapeutix initiated with a Buy at Chardan
- Promising Developments and Strategic Advancements Support Buy Rating for Ocular Therapeutix
- Ocular Therapeutix: Strategic Advancements and Market Potential Drive Buy Rating
- Ocular Therapeutix receives FDA agreement under SPA for trial of AXPAXLI
- Optimistic Buy Rating for Ocular Therapeutix Driven by Promising Clinical Trials and Strategic Decisions